Interest of Magnetic Resonance Imaging in the Diagnosis of Upper Urinary Tract Invasive Tumours
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital, Toulouse
About this trial
Upper urinary tract invasive cancer magnetic resonance imaging diagnosis
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patient over 18 years of age with a suspected upper urinary tract tumour based on the presence of a suspicious lesion on a uro-computed tomography scan
Have given free, informed and signed consent
Be affiliated to a social security scheme
Disqualifiers
Renal failure not allowing the injection of iodinated contrast media (Glomerular filtration rate <30mL/min)
Subject under legal protection (guardianship or curatorship)
Pregnant or breastfeeding woman
Person participating in another research study or having participated in a protocol with an exclusion period still in progress at inclusion
Trial design
Design model
Single group
Treatments tested in this trial
Upper urinary tract magnetic resonance imaging
RadiationPatients with a suspected malignant tumour of the upper urinary excretory tract based on the presence of a suspicious lesion on a uro-computed tomography scan will have a diagnostic magnetic resonance imaging of the urinary tract with Gadolinium-based contrast agents
Treatment groups
178 Participants
are divided into 1 treatment groupGroup A: Patients with upper urinary tract tumourExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Diagnostic validity (composite criteria sensitivity and specifcity) of a predefined magnetic resonance imaging sequence in the diagnosis of upper urinary tract invasive tumour
Diagnostic validity (sensitivity and specifcity) of a predefined magnetic resonance imaging sequence in the diagnosis of upper urinary tract invasive tumour (taking as reference the pathological analysis \[gold standard\] or biopsy with 3 months Uro-CT).
Time frame
3 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: